December 13, 2021
From medication to legislation, multiple developments have advanced the pharmacy profession this year.
October 18, 2021
Merck and Ridgeback Biotherapeutics have announced their submission of an EUA application to the FDA for an oral antiviral medication for the treatment of COVID-19.
August 05, 2021
Five medications are currently approved by the FDA for chronic weight management.
July 27, 2021
Sol-Gel Technologies has created a single-application acne treatment cream, combining 2 commonly used ingredients: tretinoin and benzoyl peroxide.
July 26, 2021
The FDA has approved the AstraZeneca once-weekly injectable therapy for use in children aged 10 to 17 years.
July 14, 2021
On June 2,2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls who have begun menstruating.
June 18, 2021
The FDA has approved OTC azelastine HCl .15% (Astepro Allergy; Bayer).
June 09, 2021
The vaccine is indicated to prevent invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.
June 02, 2021
The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.
May 25, 2021
In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.
